Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 0.54 |
| ▸ | CA12 | O43570 | 10/20 | 0.54 |
| ▸ | CA1 | P00915 | 10/20 | 0.54 |
| ▸ | CA9 | Q16790 | 10/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 10/20 | 0.54 |
| ▸ | CA4 | P22748 | 9/20 | 0.54 |
| ▸ | CA6 | P23280 | 8/20 | 0.54 |
| ▸ | CA5A | P35218 | 8/20 | 0.54 |
| ▸ | CA7 | P43166 | 8/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 8/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31095544 | 1.00 | CA2 (0.54) | CA2CA12CA1CA9CA14 | |
| SCHEMBL390917 | 0.90 | ALDH1A1 (0.48) | CA2CA12CA1CA9CA14 | |
| SCHEMBL9294471 | 0.83 | CDC25B (0.55) | CA2CA12CA1CA9CA14 | |
| SCHEMBL11122407 | 0.83 | CA2 (0.55) | CA2CA12CA1CA9CA14 | |
| SCHEMBL1413156 | 0.81 | CA2 (0.54) | CA2CA12CA1CA9CA14 | |
| SCHEMBL4953803 | 0.80 | HTR6 (0.67) | CA2CA12CA1CA9CA14 | |
| SCHEMBL11683705 | 0.79 | CA2 (0.52) | CA2CA12CA1CA9CA14 | |
| SCHEMBL9367132 | 0.79 | CA1 (0.47) | CA2CA12CA1CA9CA14 | |
| SCHEMBL115254 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TSHRCYP3A4THRBHPGD | |
| SCHEMBL29349546 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TSHRCYP3A4THRBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3670490-B1 | METHOD OF PURIFYING PINE CHEMICAL COMPOSITIONS FROM ALDEHYDES | KRATON POLYMERS LLC (US) | 2023-01-18 | — | — | EP | claimed |
| EP-3670490-A1 | METHOD OF PURIFYING PINE CHEMICAL COMPOSITIONS FROM ALDEHYDES | Kraton Polymers LLC (US) | 2020-06-24 | — | — | EP | claimed |
| US-20200165191-A1 | Method of Purifying Pine Chemical Compositions from Aldehydes | KRATON POLYMERS LLC (US) | 2020-05-28 | — | — | US | claimed |
| US-5115089-A | Heat resistant polymers for electrical insulation, protective coatings for electronics formed by reaction of tetracarboxylic dianhydrides and diaminoamides and diamines | HITACHI CHEMICAL CO., LTD. (JP) | 1992-05-19 | — | — | US | claimed |
| WO-2025108234-A1 | COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 四川科伦药物研究院有限公司 | 2025-05-30 | — | — | WO | disclosed |
| US-11643396-B2 | BRD4-kinase inhibitors as cancer therapeutics | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| EP-3670490-B1 | METHOD OF PURIFYING PINE CHEMICAL COMPOSITIONS FROM ALDEHYDES | KRATON POLYMERS LLC (US) | 2023-01-18 | — | — | EP | disclosed |
| CN-111471049-B | Organic fluorescent molecular cage compound and preparation method thereof | 上海市刑事科学技术研究院 | 2022-10-14 | — | — | CN | disclosed |
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | CTXT PTY LIMITED (AU) | 2021-12-09 | — | — | US | disclosed |
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | CTXT PTY LIMITED (AU) | 2021-12-09 | — | — | US | disclosed |
| US-20200407328-A1 | BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2020-12-31 | — | — | US | disclosed |
| US-10822302-B2 | Method of purifying pine chemical compositions from aldehydes | KRATON POLYMERS LLC (US) | 2020-11-03 | — | — | US | disclosed |
| EP-0311374-A2 | Dicylcohexyl-3,4,3'4'-tetra-carboxylic acid or dianhydride thereof and polyamide-acid and polymide obtained therefrom | Hitachi Chemical Co., Ltd. (JP) | 1989-04-12 | — | — | EP | disclosed |
| EP-0308270-A2 | Processes for preparation of polyimide-isoindoquinazoline dione and precursor thereof | Hitachi Chemical Co., Ltd. (JP) | 1989-03-22 | — | — | EP | disclosed |
| US-4758476-A | Polyimide precursor resin composition and semiconductor device using the same | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4650849-A | Photosensitive curable resin composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1987-03-17 | — | — | US | disclosed |
| EP-0184937-A2 | Polyimide precursor resin composition and semiconductor device using the same | Hitachi Chemical Co., Ltd. (JP) | 1986-06-18 | — | — | EP | disclosed |
| US-4497922-A | Compositions of materials for forming protective film in semiconductor device | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1985-02-05 | — | — | US | disclosed |
| US-4338426-A | Intermediate, copolymer resin and production thereof | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1982-07-06 | — | — | US | disclosed |
| US-4225702-A | Method of preparing polyamide acid type intermediates for processing of semiconductors | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407328-A1 | BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS | BRD4, BICRA, BRDT | CA2 4824/4885CA12 4724/4885CA1 4861/4885 |
| US-20210380548-A1 | Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family | KAT5, KAT6A, KAT2A | CA2 4004/4885CA12 4594/4885CA1 3478/4885 |
| US-11643396-B2 | BRD4-kinase inhibitors as cancer therapeutics | BRD4, BICRA, BRDT | CA2 4824/4885CA12 4724/4885CA1 4861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.